New oxygen method tested for COPD emergencies
NCT ID NCT03488628
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether high-flow nasal oxygen therapy works as well as standard noninvasive ventilation for people with a moderate COPD flare-up. Fifty-one patients were randomly assigned to one of the two treatments for the first 24 hours. The main goal was to see how each method affected blood gas levels and safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- High-flow nasal oxygen therapy
- What this could lead to
- If this works, it could offer a more comfortable breathing support option for COPD flare-ups, potentially reducing the need for face masks.
- What could go wrong
- This is a small pilot study with only 51 patients, so results may not apply to everyone. It also does not test long-term outcomes or survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY DISEASE, CHRONIC OBSTRUCTIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHR d'Orléans
Orléans, 45067, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection ease COPD and cut Flare-Ups?
- Virtual Nurse-Social worker team aims to ease symptoms for veterans with heart failure and COPD
- Double-Duty inhaler aims to ease breathing in COPD
- Could AI help pharmacists give better advice?
- New COPD drug tested across chinese, japanese, and european volunteers
- New digital tool aims to simplify care for seniors with multiple conditions